Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 15, 2022 - Issue
Submit an article Journal homepage
164
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Clopidogrel Use and CYP2C19 Genotypes in Patients Undergoing Vascular Intervention Procedure: A Hospital-Based Study

Yi-Ju Liao1 Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan
,
Tzu-Hung Hsiao2 Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan;3 Department of Public Health, Fu Jen Catholic University, New Taipei City, Taiwan;4 Institute of Genomics and Bioinformatics, National Chung Hsing University, Taichung, Taiwan
,
Ching-Heng Lin2 Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan;3 Department of Public Health, Fu Jen Catholic University, New Taipei City, Taiwan;5 Institute of Public Health and Community Medicine Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan;6 Department of Industrial Engineering and Enterprise Information, Tunghai University, Taichung, TaiwanORCID Iconhttps://orcid.org/0000-0002-2450-6108
ORCID Icon,
Chun-Sheng Hsu7 Department of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung, Taiwan;8 Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan;9 School of Medicine, National Defense Medical Center, Taipei, Taiwan;10 Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan
,
Yen-Lin Chang1 Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan;8 Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung, Taiwan
,
Yu-Wei Chen11 Cardiovascular Center, Taichung Veterans General Hospital, Taichung, TaiwanORCID Iconhttps://orcid.org/0000-0003-0430-4135
ORCID Icon,
Chiann-Yi Hsu2 Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan;12 Biostatistics Task Force of Taichung Veterans General Hospital, Taichung, TaiwanORCID Iconhttps://orcid.org/0000-0002-2941-3023
ORCID Icon,
Yi-Ming Chen2 Department of Medical Research, Taichung Veterans General Hospital, Taichung, Taiwan;10 Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan;13 Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan;14 Rong Hsing Research Center for Translational Medicine & Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan;15 School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7593-3065
ORCID Icon &
Ming-Fen Wu1 Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan
 show all
Pages 81-89 | Published online: 02 Feb 2022

References

  • Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;134(10):e123–e155. doi:10.1161/CIR.0000000000000404
  • Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease. J Am Coll Cardiol. 2017;69(11):e71–e126. doi:10.1016/j.jacc.2016.11.007
  • Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: a Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–e467. doi:10.1161/STR.0000000000000375
  • Bristol-Myers Squibb Sanofi Pharmaceuticals Partnership. Plavix® (Clopidogrel) Tablets [Prescribing Information]. Bridgewater, NJ: Bristol-Myers Squibb Sanofi Pharmaceuticals Partnership; 2021.
  • Scott SA, Sangkuhl K, Stein CM, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther. 2013;94(3):317–323. doi:10.1038/clpt.2013.105
  • Duarte JD, Cavallari LH. Pharmacogenetics to guide cardiovascular drug therapy. Nat Rev Cardiol. 2021;18(9):649–665. doi:10.1038/s41569-021-00549-w
  • Pereira NL, Farkouh ME, So D, et al. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: the TAILOR-PCI Randomized Clinical Trial. JAMA. 2020;324(8):761–771. doi:10.1001/jama.2020.12443
  • Pan Y, Chen W, Xu Y, et al. Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Circulation. 2017;135(1):21–33. doi:10.1161/CIRCULATIONAHA.116.024913
  • Bačković D, Ignjatović S, Rakićević L, et al. Influence of Cyp2c19*2 Gene Variant on Therapeutic Response During Clopidogrel Treatment in Patients with Carotid Artery Stenosis. J Med Biochem. 2016;35(1):26–33. doi:10.1515/jomb-2015-0009
  • Zhu WY, Zhao T, Xiong XY, et al. Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia. Sci Rep. 2016;6:25478. doi:10.1038/srep25478
  • Wei C-Y, Yang J-H, Yeh E-C, et al. Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese. Npj Genomic Medicine. 2021;6(1):10. doi:10.1038/s41525-021-00178-9
  • Lee YC, Liao YC, Chang FC, Huang HC, Tsai JY, Chung CP. Investigating CYP2C19 loss-of-function allele statuses and their association with stroke of different etiologies in a Taiwanese population. J Chin Med Assoc. 2019;82(6):469–472. doi:10.1097/JCMA.0000000000000101
  • Liou YH, Lin CT, Wu YJ, Wu LS. The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese population. J Hum Genet. 2006;51(10):857. doi:10.1007/s10038-006-0034-0
  • Charfi R, Mzoughi K, Boughalleb M, et al. Response to clopidogrel and of the cytochrome CYP2C19 gene polymorphism. Tunis Med. 2018;96(3):209–218.
  • Kim HS, Chang K, Koh YS, et al. CYP2C19 poor metabolizer is associated with clinical outcome of clopidogrel therapy in acute myocardial infarction but not stable angina. Circ Cardiovasc Genet. 2013;6(5):514–521. doi:10.1161/CIRCGENETICS.113.000109
  • Brott TG, Halperin JL, Abbara S, et al. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke. 2011;42(8):e464–e540. doi:10.1161/STR.0b013e3182112cc2

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.